Cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogías

ackground: Hereditary nonpolyposis colorectal cancer (HNPCC) accounts for 3 to 5% of all colorectal cancer (CC). It is an autosomal dominant syndrome with 80% of penetrance for this disease. Aim: To analyze the pedigree and surgical treatment of HNPCC. Patients and methods: We retrospectively analyzed our database of CC selecting patients with HNPCC according to clinical criteria (Amsterdam II). We characterized our patient's pedigrees with telephonic interviews. Results: From 1111 patients operated on with CC we identified 13 (1.17%) with HNPCC. The mean age at diagnosis was 41.6 years (range: 23-75). Sixty two percent presented in International Union Against Cancer (UICC) stages I or II and none in stage IV. Seventy one percent of tumors were proximal to splenic flexure. In 5 patients the diagnosis of HNPCC was made postoperatively, after diagnosis of CC in their relatives. In all but one of the 8 patients with preoperative diagnosis of HNPCC, we performed a total colectomy. From the remaining 6 patients with partial colectomy, 2 developed metachronic CC. Two patients died of cancer. From 101 persons in the 4 families, 25 have developed neoplasia: 18 CC, 3 endometrial cancer and 4 other tumors. Twenty eight relatives were eligible for colonoscopic screening, but only 21% of them have been screened appropriately. Conclusions: Preoperative diagnosis should change the surgical treatment of HNPCC, preventing metachronic disease. Primary colonoscopic screening allowed us to diagnose CC in early stages, nonetheless most of eligible relatives have not followed recommended frequency for colonoscopy (Rev Méd Chile 2004; 132: 539-47).

Saved in:
Bibliographic Details
Main Authors: Fullerton,Demian A, López K,Francisco, Rahmer O,Alejandro
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2004
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000500002
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872004000500002
record_format ojs
spelling oai:scielo:S0034-988720040005000022005-11-18Cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogíasFullerton,Demian ALópez K,FranciscoRahmer O,Alejandro Colonic neoplasms Pedigree Rectal neoplasms ackground: Hereditary nonpolyposis colorectal cancer (HNPCC) accounts for 3 to 5% of all colorectal cancer (CC). It is an autosomal dominant syndrome with 80% of penetrance for this disease. Aim: To analyze the pedigree and surgical treatment of HNPCC. Patients and methods: We retrospectively analyzed our database of CC selecting patients with HNPCC according to clinical criteria (Amsterdam II). We characterized our patient's pedigrees with telephonic interviews. Results: From 1111 patients operated on with CC we identified 13 (1.17%) with HNPCC. The mean age at diagnosis was 41.6 years (range: 23-75). Sixty two percent presented in International Union Against Cancer (UICC) stages I or II and none in stage IV. Seventy one percent of tumors were proximal to splenic flexure. In 5 patients the diagnosis of HNPCC was made postoperatively, after diagnosis of CC in their relatives. In all but one of the 8 patients with preoperative diagnosis of HNPCC, we performed a total colectomy. From the remaining 6 patients with partial colectomy, 2 developed metachronic CC. Two patients died of cancer. From 101 persons in the 4 families, 25 have developed neoplasia: 18 CC, 3 endometrial cancer and 4 other tumors. Twenty eight relatives were eligible for colonoscopic screening, but only 21% of them have been screened appropriately. Conclusions: Preoperative diagnosis should change the surgical treatment of HNPCC, preventing metachronic disease. Primary colonoscopic screening allowed us to diagnose CC in early stages, nonetheless most of eligible relatives have not followed recommended frequency for colonoscopy (Rev Méd Chile 2004; 132: 539-47).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.132 n.5 20042004-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000500002es10.4067/S0034-98872004000500002
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Fullerton,Demian A
López K,Francisco
Rahmer O,Alejandro
spellingShingle Fullerton,Demian A
López K,Francisco
Rahmer O,Alejandro
Cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogías
author_facet Fullerton,Demian A
López K,Francisco
Rahmer O,Alejandro
author_sort Fullerton,Demian A
title Cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogías
title_short Cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogías
title_full Cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogías
title_fullStr Cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogías
title_full_unstemmed Cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogías
title_sort cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogías
description ackground: Hereditary nonpolyposis colorectal cancer (HNPCC) accounts for 3 to 5% of all colorectal cancer (CC). It is an autosomal dominant syndrome with 80% of penetrance for this disease. Aim: To analyze the pedigree and surgical treatment of HNPCC. Patients and methods: We retrospectively analyzed our database of CC selecting patients with HNPCC according to clinical criteria (Amsterdam II). We characterized our patient's pedigrees with telephonic interviews. Results: From 1111 patients operated on with CC we identified 13 (1.17%) with HNPCC. The mean age at diagnosis was 41.6 years (range: 23-75). Sixty two percent presented in International Union Against Cancer (UICC) stages I or II and none in stage IV. Seventy one percent of tumors were proximal to splenic flexure. In 5 patients the diagnosis of HNPCC was made postoperatively, after diagnosis of CC in their relatives. In all but one of the 8 patients with preoperative diagnosis of HNPCC, we performed a total colectomy. From the remaining 6 patients with partial colectomy, 2 developed metachronic CC. Two patients died of cancer. From 101 persons in the 4 families, 25 have developed neoplasia: 18 CC, 3 endometrial cancer and 4 other tumors. Twenty eight relatives were eligible for colonoscopic screening, but only 21% of them have been screened appropriately. Conclusions: Preoperative diagnosis should change the surgical treatment of HNPCC, preventing metachronic disease. Primary colonoscopic screening allowed us to diagnose CC in early stages, nonetheless most of eligible relatives have not followed recommended frequency for colonoscopy (Rev Méd Chile 2004; 132: 539-47).
publisher Sociedad Médica de Santiago
publishDate 2004
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000500002
work_keys_str_mv AT fullertondemiana cancercolorrectalhereditarionopoliposotratamientoquirurgicoyanalisisdegenealogias
AT lopezkfrancisco cancercolorrectalhereditarionopoliposotratamientoquirurgicoyanalisisdegenealogias
AT rahmeroalejandro cancercolorrectalhereditarionopoliposotratamientoquirurgicoyanalisisdegenealogias
_version_ 1755988132264673280